Cibus, Inc. (CBUS)
NASDAQ: CBUS · IEX Real-Time Price · USD
9.40
-0.19 (-1.98%)
At close: Jul 19, 2024, 4:00 PM
9.42
+0.02 (0.21%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Cibus Revenue
Cibus had revenue of $2.32M in the twelve months ending March 31, 2024, with 1,289.22% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $545.00K with 1,197.62% year-over-year growth. In the year 2023, Cibus had annual revenue of $1.82M with 1,057.32% growth.
Revenue (ttm)
$2.32M
Revenue Growth
+1,289.22%
P/S Ratio
105.57
Revenue / Employee
$12,678
Employees
183
Market Cap
244.92M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 1.82M | 1.66M | 1,057.32% |
Dec 31, 2022 | 157.00K | -25.83M | -99.40% |
Dec 31, 2021 | 25.99M | 2.14M | 8.96% |
Dec 31, 2020 | 23.85M | 16.56M | 226.91% |
Dec 31, 2019 | 7.30M | 7.06M | 2,991.53% |
Dec 31, 2018 | 236.00K | -272.00K | -53.54% |
Dec 31, 2017 | 508.00K | 109.00K | 27.32% |
Dec 31, 2016 | 399.00K | -873.00K | -68.63% |
Dec 31, 2015 | 1.27M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Semler Scientific | 65.88M |
Utah Medical Products | 49.04M |
Mersana Therapeutics | 38.30M |
Senseonics Holdings | 23.30M |
Immutep | 4.58M |
Atai Life Sciences | 277.00K |
Sera Prognostics | 206.00K |
CBUS News
- 30 minutes ago - Levi & Korsinsky Announces an Investigation on Behalf of Cibus, Inc. (CBUS) Shareholders Who May Have Been Affected by Fraud - Accesswire
- 1 day ago - An Investigation Has Commenced on Behalf of Cibus, Inc. Shareholders. Contact Levi & Korsinsky to Discuss your CBUS Losses. - Accesswire
- 1 day ago - SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cibus, Inc. - CBUS - GlobeNewsWire
- 3 days ago - Shareholder Rights Advocates at Levi & Korsinsky Investigate Cibus, Inc. (CBUS) Regarding Possible Securities Fraud Violations - Accesswire
- 4 days ago - Levi & Korsinsky Reminds Cibus, Inc. Investors of the Ongoing Investigation into Potential Violations of Securities Laws - CBUS - Accesswire
- 11 days ago - CBUS STOCK ALERT: Levi & Korsinsky Notifies Cibus, Inc. Investors of an Ongoing Investigation - Accesswire
- 11 days ago - Cibus, Inc. Investigation Ongoing: Contact Levi & Korsinsky to Discuss Your Rights – CBUS - Accesswire
- 12 days ago - ATTENTION CBUS SHAREHOLDERS: Investors who lost money on Cibus, Inc. are urged to contact Levi & Korsinsky about an ongoing investigation - Accesswire